[PSY75] HTA Assessment Comparison Of Orphan Drugs In France And Germany

[PSY75] HTA Assessment Comparison Of Orphan Drugs In France And Germany

2014 Value in health

Remuzat, C. | Mzoughi, O. | Rodrigues, J. | Korchagina, D. | Toumi, M. | Volume: 17, Issue: 3, Pages: A236-A237, France, Germany, orphan drug,

In context of Health Technology Assessment (HTA) decision framework, some countries (e.g. Germany) have a special regulation for orphan drugs (OD), while others (e.g. France) don’t. The aim of the study was to compare the HTA decisions, prices and reimbursements for the OD that have been evaluated in France and Germany.